• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种三种不同的甲型/苏联/92/77(H1N1)灭活流感病毒疫苗后人体中的E玫瑰花结形成细胞和体液抗体滴度

E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).

作者信息

Schmidt S, Süss J, Oehring H, Schmidt J

出版信息

Acta Virol. 1982 Dec;26(6):466-73.

PMID:6132540
Abstract

The number of E-rosette forming cells and the serum haemagglutination inhibition (HI) antibody titres were examined in 37 volunteers immediately before and 14, 28, 35 and 63 days after immunization with three inactivated influenza virus vaccines A/USSR/92/77 (H1N1)--NIB 6 and in 11 non-vaccinated controls. From the former, 10 volunteers were immunized with 1000 haemagglutinin (HA) IU per dose, 11 volunteers with the NIB 6 adsorbate vaccine (340 HA IU/dose) and 16 volunteers with a bivalent vaccine composed of 180 HA IU/dose NIB 6 and 180 HA IU/dose of influenza virus A/Bangkok X-73 (H3N2). The percentage of E-rosette forming cells was decreased in all vaccinated volunteers 14 days after vaccination; later on the values reached normal level of non-vaccinated controls or of subjects before vaccination. The number of E-rosette forming cells was in correlation with the applied virus vaccine dose, i.e. for the 1000 HA IU/dose: 29.95 +/- 11.74%, p less than 0.001 and for the 340 HA IU/dose: 47.75 +/- 11.15%, p less than 0.005; however, after administration of 180 HA IU/dose of NIB 6 in the bivalent vaccine, the value 58.65 +/- 11.5% was not significantly decreased in comparison to non-vaccinated donors. The serum HI antibody titres reached the highest level 14 days after vaccination and remained constant during the next 6 weeks. There was a correlation between decreased E-rosette values and increased serum antibody titres (p less than 0.05). The current study indicates that the number of E-rosette forming cells may serve as a further laboratory criterion for controlling the effect of inactivated influenza virus vaccines on the immune system of man.

摘要

在37名志愿者接种三种灭活流感病毒疫苗A/USSR/92/77(H1N1)-NIB 6之前以及接种后14、28、35和63天,检测了E-玫瑰花结形成细胞数量和血清血凝抑制(HI)抗体滴度,并设置了11名未接种疫苗的对照。在前者中,10名志愿者接种每剂1000血凝素(HA)国际单位的疫苗,11名志愿者接种NIB 6吸附疫苗(340 HA国际单位/剂),16名志愿者接种由180 HA国际单位/剂NIB 6和180 HA国际单位/剂甲型流感病毒A/曼谷X-73(H3N2)组成的二价疫苗。接种疫苗14天后,所有接种志愿者的E-玫瑰花结形成细胞百分比均下降;随后这些值达到未接种疫苗对照或接种前受试者的正常水平。E-玫瑰花结形成细胞数量与所应用的病毒疫苗剂量相关,即对于1000 HA国际单位/剂:29.95±11.74%,p<0.001;对于340 HA国际单位/剂:47.75±11.15%,p<0.005;然而,在二价疫苗中接种180 HA国际单位/剂的NIB 6后,与未接种疫苗的供体相比,58.65±11.5%的值没有显著下降。血清HI抗体滴度在接种疫苗14天后达到最高水平,并在接下来的6周内保持稳定。E-玫瑰花结值降低与血清抗体滴度升高之间存在相关性(p<0.05)。当前研究表明,E-玫瑰花结形成细胞数量可作为控制灭活流感病毒疫苗对人体免疫系统作用效果的进一步实验室标准。

相似文献

1
E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).接种三种不同的甲型/苏联/92/77(H1N1)灭活流感病毒疫苗后人体中的E玫瑰花结形成细胞和体液抗体滴度
Acta Virol. 1982 Dec;26(6):466-73.
2
Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.连续数年接种相同流感疫苗毒株的成年人对流感疫苗的抗体反应。
J Med Virol. 2007 Mar;79(3):320-5. doi: 10.1002/jmv.20801.
3
Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?6至23个月大儿童的流感疫苗免疫原性:启动免疫是否需要相同抗原?
Pediatrics. 2006 Sep;118(3):e570-8. doi: 10.1542/peds.2006-0198.
4
Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.流感病毒样颗粒比全病毒灭活流感病毒或重组血凝素引发更广泛的免疫反应。
Vaccine. 2007 May 10;25(19):3871-8. doi: 10.1016/j.vaccine.2007.01.106. Epub 2007 Feb 15.
5
Immune response to influenza vaccination in community-dwelling Chinese elderly persons.社区居住的中国老年人对流感疫苗接种的免疫反应。
Vaccine. 2006 Jun 19;24(25):5371-80. doi: 10.1016/j.vaccine.2006.04.032. Epub 2006 May 3.
6
Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.甲型 H1N1v 2009 流感疫苗单剂接种的免疫原性和安全性:含或不含 AS03A 佐剂的随机、双盲试验初步报告。
Vaccine. 2010 Feb 17;28(7):1740-5. doi: 10.1016/j.vaccine.2009.12.014. Epub 2009 Dec 22.
7
Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.类风湿关节炎患者的流感疫苗接种:利妥昔单抗对体液免疫反应的影响。
Ann Rheum Dis. 2008 Jul;67(7):937-41. doi: 10.1136/ard.2007.077461. Epub 2007 Nov 2.
8
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.通过鼻内共同给予杆状病毒表面展示的血凝素(HA)和重组霍乱毒素B亚单位(CTB)作为佐剂,对小鼠进行针对H5N1流感病毒攻击的保护性免疫。
Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002. Epub 2008 Sep 10.
9
Characteristics of cell-mediated immunity after oral administration of a live influenza vaccine.
Acta Virol. 1982 Dec;26(6):474-80.
10
Comparison of one- and two-dose regimens of influenza vaccine for elderly men.老年男性流感疫苗单剂量与双剂量接种方案的比较。
CMAJ. 1987 Oct 15;137(8):722-6.